Soluble L-selectin (sCD62L) umbilical cord plasma levels increase with gestational age

Area of Science:

• Immunology
• Neonatology
• Biochemistry

Background:

• L-Selectin (CD62L) is a leukocyte adhesion molecule crucial for immune cell trafficking.
• Soluble L-selectin (sCD62L) retains functional activity and can be measured in biological fluids.
• Understanding sCD62L in newborns is important for assessing immune status and developmental factors.

Purpose of the Study:

• To quantify soluble L-selectin (sCD62L) levels in human newborn plasma.
• To investigate the correlations between sCD62L levels and various neonatal parameters.
• To identify factors influencing sCD62L concentrations in the neonatal period.

Main Methods:

• Development of a sensitive enzyme-linked immunoassay for sCD62L quantitation.
• Measurement of sCD62L in umbilical cord plasma from 255 newborns (23-43 wk gestational age).
• Correlation analysis with gestational age, birth weight, absolute neutrophil counts, and absolute normoblast counts.

Main Results:

• sCD62L levels (1.14-13.8 pmol/mL) significantly correlated with gestational age (r=0.71), birth weight (r=0.66), and absolute neutrophil counts (r=0.62).
• Gestational age and absolute neutrophil counts were the primary independent predictors of sCD62L levels in multiple regression analysis.
• Decreased sCD62L was associated with multiple gestation, and changes related to meconium or infection were explained by gestational age and neutrophil counts.

Conclusions:

• Neonatal sCD62L levels are closely linked to gestational age and neutrophil counts.
• sCD62L serves as a potential biomarker for assessing neonatal development and immune readiness.
• Further research can explore the clinical implications of sCD62L variations in specific neonatal conditions.